New Trial Testing Benlysta as Injectable
Thursday, December 15, 2011
The Lupus Research Institute is pleased to alert people with lupus of a new Phase III trial testing the efficacy, safety and tolerability of the recently approved Benlysta(r) as a once-a-week injectable rather than the existing intravenous formulation. For more information, visit clinicaltrials.gov and search for trial NCT01484496.
On the go?
Text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and Data Rates May Apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms